# Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer

> **NCT00352105** · PHASE1,PHASE2 · COMPLETED · sponsor: **David Adelstein** · enrollment: 60 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **DRUG:** Iressa
- **RADIATION:** hyperfractionated radiation therapy

## Key facts

- **NCT ID:** NCT00352105
- **Lead sponsor:** David Adelstein
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-09
- **Final completion:** 2010-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2012-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00352105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00352105, "Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00352105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*